Summary been studied in transfected cells. Catalytically defective mutants and mutants lacking either or both of the two The MAP kinase ERK2 is widely involved in eukaryotic activating phosphorylation sites tyrosine-185 and threosignal transduction. Upon activation it translocates to nine-183 (in ERK2) undergo stimulus-dependent relocalthe nucleus of the stimulated cell, where it phosphoryization (Chen et al., 1992; Gonzalez et al., 1993 ; Lenorlates nuclear targets. We find that nuclear accumulamand et al., 1993). Therefore, nuclear accumulation of tion of microinjected ERK2 depends on its phosphoryERKs was presumed to be independent of their activity lation state rather than on its activity or on upstream and phosphorylation state. An upstream component or components of its signaling pathway. Phosphorylated a separate stimulus-dependent pathway seemed possi-ERK2 forms dimers with phosphorylated and unphosble regulators of ERK1/2 nuclear localization.
Introduction lower than that for unphosphorylated dimers, suggesting that active ERK2 exists as a dimer in cells. DimerizaMitogen-activated protein (MAP) kinases are ubiquitous tion of unphosphorylated with phosphorylated ERK2 faprotein kinases involved in signal transduction in eukarcilitated import of the unphosphorylated protein and yotic organisms (Hunter, 1995;  Waskiewicz may account for the stimulus-dependent translocation and Cooper, 1995; Kyriakis and Avruch, 1996; Lewis et of mutants lacking phosphorylation sites. The crystal al., 1998; Robinson and Cobb, 1997) . Their actions are structure of phosphorylated ERK2 (Canagarajah et al., important for a panoply of cellular functions from prolif-1997) revealed a dimer interface consistent with the bioeration and development to inflammatory responses chemical findings. Mutants of ERK2 that were unable to and programmed cell death. The best-studied MAP kidimerize were less able to accumulate in the nucleus nases, extracellular signal-regulated kinases (ERKs) 1 even if phosphorylated. and 2, phosphorylate proteins from the plasma memThese studies indicate that the nuclear accumulation brane to the nucleus (Moriguchi et al., 1996) . Localization of MAP kinase depends on its phosphorylation state at their sites of action is one determinant of their funcrather than on its activity. Phosphorylation induces its tions. In unstimulated cells, ERK1/2 are largely cytodimerization, which is required for its nuclear location. plasmic. Upon activation, both kinases translocate to Other MAP kinase family members also formed dimers the nucleus in part (Chen et al., 1992 (Chen et al., , 1996 ; Gonzalez when phosphorylated. The formation of dimers upon et Lenormand et al., 1993; Reszka et al., 1995;  activation is common to the MAP kinase family and is Fukuda et al., 1997) ; quantitation reveals that half of the likely to be an inherent part of their mechanisms of endogenous ERK2 remains in the cytoplasm, primarily action. associated with the microtubule cytoskeleton (Reszka et al., 1995) . The duration of activation of MAP kinases Results influences the extent of their nuclear translocation and, thus, their access to nuclear substrates such as ternary Phosphorylation of ERK2 Is Sufficient to Cause Its Nuclear Accumulation Phosphorylated ERK2 microinjected into the cytoplasm § To whom correspondence should be addressed.
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of quiescent rat embryo fibroblast (REF 52) cells was detected in the nucleus using anti-phosphoERK antibodies (Figures 1A and 1B) . Translocation was rapid; nuclear phosphorylated ERK2 was detected within 1 min after cytoplasmic injection. The antibodies also stained the cytoplasm of injected cells, consistent with previous findings that only a portion of the phosphorylated ERK2 accumulated in the nucleus (Reszka et al., 1995; Cheng et al., 1996) . Nuclear uptake of phosphorylated ERK2 was also observed following cytoplasmic injection of Swiss 3T3 and human foreskin fibroblasts (data not shown). Thus, in different cell lines both immortalized and primary, phosphorylation of ERK2 promotes its accumulation in the nucleus.
Extracellular Stimuli Induce Nuclear Uptake of ERK2
To confirm that microinjected unphosphorylated ERK2 was capable of translocating to the nucleus in response to a stimulus, Myc-epitope tagged ERK2 was injected and detected using an anti-Myc antibody. Unphosphorylated Myc-ERK2 appeared in the nucleus of unstimulated cells only transiently (5 min) after injection into the cytoplasm (data not shown). Thereafter, it was seen in the cytoplasm. However, it accumulated in the nucleus when cells were stimulated with phorbol ester or serum (data not shown). Unphosphorylated wild-type or kinase-deficient K52R Myc-ERK2 injected in the cytoplasm remained there for hours ( Figures 1G and 1H ), although the immunofluorescent signal became weak. Translocation of this cytoplasmic protein to the nucleus occurred upon stimulation with platelet-derived growth factor up to 3 hr after injection ( Figures 1I and 1J ), indicating that the injected protein could move to the nucleus even hours after it was introduced into cells.
Thiophosphorylation of ERK2 Enhances Its Nuclear Accumulation
The studies above indicated that phosphorylation of ERK2 determined its intracellular distribution. However, the duration of the immunofluorescent signal using the anti-phosphoERK antibodies was short (data not shown). This suggested that injected ERK2 was rapidly dephosphorylated. To reduce its susceptibility to dephosphorylation by endogenous phosphatases, ERK2 was thiophosphorylated in vitro (Cassel and Glaser, 1982) . sistent signal than observed for phosphorylated ERK2.
(C-F) Thiophosphorylated ERK2 (3 mg/ml) was microinjected with
Similar results were obtained with thiophosphorylated rat IgG at 2 mg/ml. Cells were fixed after 30 min (C and D) and 3 hr K52R ERK2 and ERK1, although ERK1 was neither re- (E and F) and stained with the anti-IgG antibody (C and E) and with the anti-active ERK antibody (D and F). Cells injected with tained as long nor as uniformly distributed within nuclei thiophosphorylated K52R ERK2 showed similar nuclear accumula-(data not shown).
tion for at least 3 hr.
To examine the nuclear retention of ERK2, unphos-(G-J) K52R Myc-ERK2 (3.5 mg/ml) was microinjected with rabbit phorylated, phosphorylated, or thiophosphorylated ERK2
IgG at 3 mg/ml. Cells were unstimulated for 3 hr (G and H) K52R Myc-ERK2 (1.8 mg/ml) was microinjected with rat IgG at 2-3 (E-H) K52R Myc-ERK2 (3.4 mg/ml) was microinjected with rabbit mg/ml. Cells were fixed after 30 min and stained with anti-IgG (E) IgG at 2-3 mg/ml. Cells were fixed 5 min (E and F) and 2 hr (G and and the anti-Myc antibody (F). H) after injection and stained with the anti-IgG antibody (E and G) (G and H) Thiophosphorylated K52R ERK2 (1.8 mg/ml) was mixed and with the anti-Myc antibody (F and H). Similar results were obwith T183A,Y185F Myc-ERK2 (2.2 mg/ml) and microinjected with rat tained with wild-type Myc-ERK2. For each panel 2-3 experiments IgG at 4 mg/ml. After 30 min, cells were stained with the anti-IgG of 50-100 cells were performed.
antibody (G) and the anti-Myc antibody (H). Panels represent 3-5 experiments of 50-150 cells.
nuclear from shortly after (30 min; Figures 2A and 2B) to at least 2 hr ( Figures 2C and 2D ) after injection into K52R ERK2 demonstrate that ERK2 activity is not necessary for nuclear accumulation, consistent with earlier the nucleus. In contrast, unphosphorylated K52R Myc-ERK2 remained in the nucleus less than 5 min (Figures studies (Gonzalez et al., 1993; Lenormand et al., 1993) . 2E and 2F) before beginning to redistribute to the cytoplasm. Immunofluorescence from unphosphorylated Phosphorylated ERK2 Facilitates Nuclear Uptake of Unphosphorylated ERK2 K52R ERK2 disappeared from the nucleus ( Figure 2H ), while the coinjected IgG remained nuclear ( Figure 2G ).
In contrast to our finding that phosphorylation of ERK2 was sufficient to induce its nuclear import, previous studThiophosphorylation stabilized the nuclear localization of ERK2. Furthermore, results with thiophosphorylated ies in transfected cells indicated that phosphorylation His6-H176E L4A ERK2 was thiophosphorylated and His 6 -ERK2 was from the coexpression system. Proteins were treated with phosphoprotein phosphatase 2A (PP2A) or phosphotyrosine phosphatase 1 (PTP1) as indicated and applied to Superdex G-75 (A). Arrows indicate Stokes radii of the standard bovine serum albumin (36 Å ), ovalbumin (33 Å ), chymotrypsinogen (21 Å ), and ribonuclease A (16 Å ). Horizontal axis is the time of elution. Phosphorylated (B) and unphosphorylated (C) ERK2 were sedimented to equilibrium at 9000 rpm. The theoretical concentration gradients if only dimer (1) or monomer (2) were present are indicated. Best-fit lines to a monomer-dimer equilibrium model and the distribution of the residuals are shown.
of ERK2 was not necessary for its import (Lenormand translocated into the nucleus (data not shown). Translocation was short-lived, consistent with the dephoset al., 1993). Therefore, we examined the distribution of ERK2 in which both of the activating phosphorylaphorylation of wild-type ERK2. Thus, nuclear translocation of K52R Myc-ERK2 was not due to overloading the tion sites T183 and Y185 were mutated. As expected, T183A,Y185F Myc-ERK2 microinjected into the cytocell with ERK protein (Fukuda et al., 1997) . However, when unphosphorylated K52R Myc-ERK2 was coinjected plasm translocated to the nucleus after stimulation of cells with phorbol ester (Figures 3A and 3B) . In the abwith untagged thiophosphorylated kinase-deficient K52R ERK2, rapid nuclear accumulation of unphosphorylated sence of a stimulus, this mutant remained in the cytoplasm ( Figures 3C and 3D ).
K52R Myc-ERK2 was observed, at 30 min (Figures 3E and 3F) and for up to 3 hr. These results suggest that In spite of the fact that phosphorylation was sufficient for nuclear import, phosphorylation was not required for phosphorylation of ERK2 facilitates the formation of ERK complexes that are imported. stimulus-induced import whether protein was introduced by transfection or microinjection. We considered two possible explanations: 1) the stimulus caused nuclear import of unphosphorylated mutant ERK2 by a Phosphorylated ERK2 Forms Dimers To determine if ERK2 oligomerizes, we subjected phosmechanism dependent on the activity of endogenous ERK2; or 2) phosphorylated ERK2 formed an importphorylated and unphosphorylated ERK2 to gel filtration on Superdex G75. Phosphorylated ERK2 eluted in two competent complex with unphosphorylated ERK2. If ERK2 activity was required for nuclear uptake of coinpoorly resolved peaks with apparent Stokes radii of 35 and 27 Å ( Figure 4A , top), consistent with the existence jected, unphosphorylated ERK2, then import would occur via an activity-dependent mechanism. If so, then of monomers and dimers. Unphosphorylated ERK2 eluted as a single peak at 24Å ( Figure 4A , next to bottom). either ERK2 phosphorylation or activity would be sufficient for nuclear accumulation. If ERK2 activity was Dephosphorylation of ERK2 with either phosphothreonine-or phosphotyrosine-selective phosphatases connot required and instead phosphorylated, catalytically defective K52R ERK2 was sufficient to induce import verted the faster eluting protein into the more slowly eluting form ( Figure 4A , middle panels). Thus, interconof unphosphorylated protein, then protein complexes would be implicated.
version of these two species is catalyzed by phosphorylation/dephosphorylation. To distinguish between these hypotheses, combinations of wild-type and K52R ERK2 in phosphorylated
To define the nature of the ERK2 complexes, phosphorylated and nonphosphorylated ERK2 were anaand unphosphorylated states were injected into the cytoplasm. When a mixture of unphosphorylated K52R lyzed by equilibrium sedimentation. The data were modeled on the basis of a system composed of two ideal Myc-ERK2 together with phosphorylated untagged wildtype ERK2 was injected, kinase-defective Myc-ERK2
solutes, a monomer of M r 42,000 and a dimer of 84,000.
Comparison of the data to the model showed an excellent fit with a random distribution of the residuals. Phosphorylated ERK2 sedimented primarily as an 84 kDa species ( Figure 4B ) in multiple experiments. In contrast, unphosphorylated ERK2 sedimented as a mixture of a lesser amount of the 84 kDa and a greater amount of the 42 kDa species, consistent with unphosphorylated ERK2 existing primarily as a monomer ( Figure 4C ). Thus, the first peak eluted from the gel filtration column is an ERK2 dimer. Modeling the data as a two component self-association system and using a molar extinction coefficient of 45,000 for ERK2, the calculated dimer KD for phosphorylated ERK2 was 7.5 nM. In contrast, the dimer KD for unphosphorylated ERK2 was nearly 3000-fold higher at approximately 20 M. We next tested the capacity of wild-type ERK2 to form dimers with unphosphorylated ERK2 and mutants. Phosphorylated wild-type ERK2 was mixed with unphosphorylated ERK2, K52R Myc-ERK2, or with the phosphorylation site mutant T183A,Y185F Myc-ERK2. ERK2 activity was detected in the anti-Myc immunoprecipitates of K52R ERK2 or T183A,Y185F ERK2 but not in the immunoprecipitates of untagged unphosphorylated ERK2 ( Figure 5A ). These data indicate that phosphorylated wild-type ERK2 can form dimers with either unphosphorylated wild-type or mutant ERK2.
As a final test of the capacity of phosphorylated ERK2 to mediate nuclear import of unphosphorylated ERK2, we determined if phosphorylated ERK2 was sufficient for import of the phosphorylation site mutant T183A,Y185F ERK2. Although stimulation of cells caused the nuclear accumulation of this mutant, T183A,Y185F Myc-ERK2 was found in the cytoplasm when microinjected alone into either the cytoplasm or the nucleus or when coinjected with unphosphorylated wild-type ERK2 ( Figures  3C and 3D ; data not shown). On the other hand, T183A,Y185F Myc-ERK2 coinjected with thiophosphorylated untagged K52R ERK2 accumulated in the nucleus ( Figures 3G and 3H) . Thus, nuclear translocation of phosphorylation-defective ERK2 mutants occurs most L333,336,341,344A, called L4A ERK2). Phosphorylated H176E L 4 A ERK2 and all other ERK2 dimer mutants Dimerization Contributes to tested had kinase activity comparable to wild-type ERK2 Phosphorylation-Dependent (data not shown), as reported previously for ERK2⌬4 Nuclear Localization (Robinson et al., 1996) . Unlike wild-type ERK2, mutants
To assess the importance of dimerization on subcellular lacking H176, H176E L 4 A ERK2, and ERK2⌬4 behaved localization of ERK2, ERK2 mutants that could not dias monomers by ultracentrifugation and by gel filtration merize were thiophosphorylated and microinjected into even when phosphorylated ( Figures 4A [bottom] and cells. When thiophosphorylated H176E L 4 A ERK2 was 5C). Thiophosphorylated ERK2⌬4 coimmunoprecipitated microinjected into the cytoplasm, like wild-type unphospoorly with wild-type ERK2 ( Figure 5B) . Mutation of the phorylated ERK2, the mutant appeared transiently in leucine residues on the interface alone was not sufficient the nucleus and rapidly relocalized to the cytoplasm. to prevent dimerization (data not shown). These studies
In contrast to thiophosphorylated ERK2, however, the confirm the location of the dimer interface identified in the crystal structure. majority of H176E L 4 A ERK2 remained in the cytoplasm This hypothetical substrate was overlaid on the ERK2 kinase dimer. An extended region of the transcription factor dimer following the phosphorylation sites within the N-terminal domain and preceding the coiled coil beginning at residue 156 of c-Fos is not shown to allow an unimpeded view of the substrate binding region and to emphasize the nature of the dimer-dimer symmetry.
Discussion

Mechanisms of Nuclear Localization of ERKs
Extracellular stimuli induce the nuclear translocation of wild-type, kinase-deficient, and phosphorylation site mutants of ERK1 and ERK2 (Gonzalez et al., 1993; Lenormand et al., 1993; Cheng et al., 1996) . To investigate requirements for their nuclear translocation, we microinjected ERKs into cells without activating the upstream signal transduction pathway. Under these conditions phosphorylated ERKs, wild-type and kinase-deficient, accumulate in the nucleus. Unphosphorylated ERKs remain primarily in the cytoplasm but translocate to the nucleus in response to a stimulus. These studies demonstrate that phosphorylation of ERKs is sufficient for their nuclear translocation and that kinase activity is not required. ERK2 dimerizes in a phosphorylation-dependent manner. ERK2 dimers may be composed of two phosphorylated molecules or one phosphorylated and one unphosphorylated molecule, a hemiactive dimer. The same is are translocated in stimulated cells. Mutants that fail to dimerize accumulate less well in the nucleus when phosphorylated. This provides strong evidence that difrom 30 min to 1.5 hr after injection ( Figures 6A-6F) . merization is part of the physiological mechanism for Faint nuclear staining was also noted. The molecules nuclear translocation of ERKs. Because certain actions detected in the cytoplasm were phosphorylated beof ERKs such as induction of neurites in PC12 cells are cause they were recognized by the anti-active ERK antidependent on their nuclear entry (Traverse et al., 1992 ; body. Thiophosphorylated ERK2⌬4 also did not accu- Marshall, 1995; Robinson et al., submitted) , the biologimulate in the nucleus, although the immunofluorescent cal significance of dimerization is great. signal from this mutant was weak. Thus, ERK2 mutants
The subcellular localization of ERKs likely arises from that do not homodimerize are found primarily in the the concerted effects of regulated nuclear import, regucytoplasm. lated nuclear export, and regulated cytoplasmic retention. Proteins smaller than 40-50 kDa readily diffuse into the nucleus (Wen et al., 1995; Gö rlich and Mattaj, 1996) , Model for Substrate Dimer-Kinase Dimer Interaction suggesting that monomeric ERKs enter the nucleus by diffusion. Our data support the idea that ERKs may enter The 2-fold symmetry of the kinase dimer matches the 2-fold symmetry or pseudosymmetry of dimeric coiledfreely by diffusion, because most of the unphosphorylated proteins tested were found transiently in the nucoil transcription factors. A plausible interaction between a MAP kinase dimer and the substrate dimer Foscleus, although they rapidly relocalized to the cytoplasm. However, active dimeric proteins, which are too Jun (Knighton et al., 1991; Glover and Harrison, 1995) could lead to the simultaneous phosphorylation of sites large for unrestricted diffusion into the nucleus, rapidly accumulate in the nucleus following introduction into in both substrate molecules as shown in the model (Figure 7C) . The model was constructed using substrate the cytoplasm. Although ERKs may dissociate and reassociate following nuclear entry, the data are consistent binding interactions defined by protein kinase inhibitor peptide contacts with cAMP-dependent protein kinase with the possibility that they are actively imported. The putative nuclear localization signal need not be (Knighton et al., 1991) fused through a loop to the coiled coil from the Fos-Jun dimer (Glover and Harrison, 1995).
intrinsic to monomeric ERKs but may arise from the [Glover and Harrison, 1995] ), and residues 6-24 of the protein kinase inhibitor bound to cyclic-AMP-dependent protein kinase (Protein Data Bank file 1atp.ent [Knighton et al., 1991] ). (A) and (B) were generated in MOLSCRIPT (Kraulis, 1991) and rendered in RASTER3D (Bacon and Anderson, 1988) . (C) was generated in GRASP (Nicholls et al., 1991) . The protein kinase inhibitor and c-Fos:c-Jun dimer coordinates were linked through a 10 residue loop.
association of phosphorylated ERKs with other prowhich dimerization influences the nuclear import of ERK2 without affecting its kinase activity. Dimerization tein(s), which are imported by a piggy-back mechanism (Jans, 1995; Gö rlich and Mattaj, 1996) . For example, is not necessary for kinase activity because ERK2 activity is concentration independent ERKs are known to associate with the substrate Rsk, which also enters the nucleus upon activation (Chen and dimerization-defective mutants have activity comparable to wild type. The crystal structure shows that et Hsiao et al., 1994; Zhao et al., 1996) . The ERK-Rsk complex may be recognized for import once dimerization does not obstruct the active sites (Canagarajah et al., 1997) . Rsk is phosphorylated by ERKs. Our data indicate, however, that ERK activity is not required for its nuclear
The physical basis for dimerization has been deduced from the crystal structure of active ERK2 and confirmed accumulation. Therefore, ERK homodimerization may be at least as significant in inducing nuclear uptake.
by mutagenesis. In active ERK2, a network of chargecharge interactions are created between the phosphoryConsistent with this conclusion, the dimerization-defective but active mutant H176E L4A ERK2 remains in the lation lip and L16 within the C-terminal extension to the catalytic core. Leucine residues on the surface of L16 cytoplasm. Dimerization of ERKs may expose a binding site for a protein containing a nuclear localization signal, interact with the same residues of a second ERK2 molecule. The ERK2 phosphorylation lip and regions interor the dimers may bind directly to a component of the import machinery. Alternatively, ERKs may be imported acting with it, including L16, become disordered in mutants lacking the tyrosine phosphorylation site (Zhang by a less-well-characterized mechanism (e.g., Pollard et al., 1996 Pollard et al., ). et al., 1995 . The low stability of the lip and L16 explains why a phosphorylated ERK2 molecule induces an unPhosphorylated and unphosphorylated ERKs are exported at different rates following microinjection into phosphorylated ERK2 molecule or mutant to dimerize with it. the nucleus, consistent with regulation of their nuclear export. The ERK2 dimer interface contains a putative
We find that p38, ERK1, and JNK/SAPK also form homodimers (unpublished data). However, they apparnuclear export sequence (MELDDLPKEKLKEL) (Wen et al., 1995) . Dimerization of ERKs may block their nuclear ently form heterodimers poorly. Preliminary results suggest that ERK1/ERK2 heterodimers are more readily disexport not only because as dimers they are too large for diffusion through nuclear pores, but also because sociable than hemiactive ERK2. The dimer interfaces in the two MAP kinases ERK2 and p38, for which structural dimerization masks this putative export signal. Replacement of this sequence does not result in nuclear retendata are available (Zhang et al., 1994; Wilson et al., 1996; Wang et al., 1997) , are different in conformation and tion of unphosphorylated protein, suggesting that it is not sufficient to control the localization of ERK2.
sequence, making heterodimerization between MAP kinase family members unlikely. On the other hand, the Finally, the regulated distribution of ERKs may involve retention of unphosphorylated ERKs in the cytoplasm many JNK/SAPK isoforms (Dé rijard et al., 1994; Kallunki et al., 1994; Gupta et al., 1996) may heterodimerize. In (Fukuda et al., 1997) or phosphorylated ERKs within the nucleus. A nuclear export signal found on the ERK this regard, a p38 splice variant, Mxi2, cloned by its twohybrid interaction with the Myc partner Max (Zervos et upstream activator MEK1 may tether ERKs in the cytoplasm; feedback phosphorylation of MEK by activated al., 1995) is truncated prior to L16 and may therefore not dimerize. As a result, Mxi2 may interfere with the ERK may allow ERKs to escape to the nucleus (Fukuda et al., 1997) . This mechanism is compatible with our phosphorylation of dimeric transcriptional regulators to which it binds. findings; however, it is not sufficient to account for our results that demonstrate nuclear accumulation of kinase-deficient phosphorylated, but not unphosphoryPhysiological Impact of MAP Kinase Dimerization lated, ERKs in the absence of cell stimulation. Nor is Many MAP kinase substrates are dimers, including basic it likely to account for the cytoplasmic localization of helix-loop-helix and leucine zipper proteins and steroid phosphorylated H176E L 4 A ERK2, which has kinase acreceptors (Hunter and Karin, 1992; Seth et al., 1992 ; tivity not significantly different from wild-type ERK2. Cheng et al., 1993; Mangelsdorf et al., 1995; Kallunki et al., 1996) . MAP kinase dimers may activate substrate dimers through a single interaction. The strucMechanisms of MAP Kinase Dimerization Dimerization upon activation is a property common to ture of the MAP kinase dimer together with data on the interactions between protein kinases and their submembers of the MAP kinase family. The monomer-dimer equilibrium for ERK2 is shifted strongly in favor of dimers strates lead to a compelling model for the interaction between a MAP kinase dimer and a dimeric transcription upon phosphorylation, with a KD of 7.5 nM for dissociation of the phosphorylated ERK2 dimer and a KD of 20 M factor. The kinase active sites are oriented on one face of the dimer, and the dimer has the same symmetry for dissociation of the unphosphorylated ERK2 dimer. Using an estimate of the intracellular concentration of as transcription factor substrates ( Figure 7 ). Residues N-terminal to the phosphoacceptor site of the substrate ERK2 in the high nanomolar range , the protein should exist primarily as a dimer in stimulated bind to a surface groove near helices D and G of the kinase (Knighton et al., 1991; Kallunki et al., 1994 ; cells and as a monomer in resting cells. Although we have been unable to demonstrate dimers in whole-cell Canagarajah et al., 1997) . Residues C-terminal to the phosphoacceptor site of substrate bind near the phoslysates, the biochemical data are unambiguous that phosphorylated ERK2 is a dimer in vitro. Furthermore, phorylation lip. ERK2 dimerization also involves the phosphorylation lip. Thus, a dimeric transcription factor the nuclear import data is compelling evidence that dimers occur in vivo. These data suggest a model in may dock onto the ERK2 dimer, with the N terminus of each chain bound to the peptide substrate binding mutagenesis impairs nuclear accumulation. Dimerizagroove. In this binding mode, the 2-fold axis of symmetry tion of these kinases introduces additional complexity of the transcription factor is parallel with the axis of in their regulation and their access to and interaction symmetry of the kinase.
with downstream targets and creates distinct thresholds The fact that dimers may be composed of phosphoryfor target activation. Thus, with the finding that MAP lated and unphosphorylated MAP kinases as a mixture kinases dimerize comes the discovery of a new paraof fully active and hemiactive dimers may have an impact digm in our understanding of these pleiotropic protein on the time course, the threshold for activation, and the kinases. efficacy of regulation of downstream substrates (see
Experimental Procedures
Chi- Ying and Ferrell, 1996) . A single interaction of hemiactive dimeric kinase with dimeric substrate will phosProteins phorylate only one subunit of the substrate dimer. With ERK2 mutants were created using the QuikChange kit (Stratagene, weak stimuli or during the decay of a response, the La Jolla, CA). Unphosphorylated and phosphorylated His6-tagged majority of ERKs may be in hemiactive dimers.
proteins were expressed and purified on Ni 2ϩ -NTA agarose and Dimerization of substrates has already been shown MonoQ Mansour et al., 1994; to influence substrate recognition by a member of the et al., 1997). ERK2 was dialyzed against 4ϫ buffer A (12.5 mM HEPES (pH 7.3), 100 mM KCl, 6.25% glycerol) and concentrated to [12] [13] [14] [15] [16] MAP kinase family (Kallunki et al., 1994;  mg/ml in a Microcon 30 concentrator (Amicon, Beverly, MA). Pro- Gupta et al., 1996) . c-Jun is phosphorylated as a conseteins were frozen in liquid nitrogen and stored at Ϫ80ЊC in small quence of its tight interaction with JNK/SAPK (Hibi et aliquots. al., 1993; Kallunki et al., 1994) . c-Jun forms heterodimers
To prepare thiophosphorylated and Myc epitope-tagged ERK2 with other related factors, some of which lack the doproteins, ERK2 and mutants were subcloned into pGEX-KG modified main necessary for tight association with JNK/SAPK so that after thrombin cleavage recombinant proteins contained Kallunki et al., 1996) . Subunits of Jun heteronly two additional N-terminal amino acids. In some cases, a Myc epitope (EQKLISEEDL) was inserted between the thrombin cleavage odimers that lack the JNK/SAPK-binding domain, such site and the ERK2 initiator methionine. Glutathione-S-transferase as JunD, are phosphorylated only if they heterodimerize (GST)-tagged proteins (Guan and Dixon, 1991) were cleaved with with Jun monomers that have the JNK/SAPK-binding thrombin (Ngai and Chang, 1991) , phenylmethylsulfonylfluoride site (Kallunki et al., 1996) . This should result in a multi-tiered activation of submM benzamidine, 150 M PMSF, 0.2 g/ml pepstatin A, 0.26 g/ml strates depending upon the number of substrate-kinaseleupeptin, 20 mM NaCl, and 15% glycerol for 1-2 hr. 50 mM NaCl binding sites, functional active sites in the kinase dimer, was added and the kinase was purified on glutathione beads and and competent phosphoacceptor sites in the substrate. MonoQ, dialyzed, Transcription factors that contain only one subunit that concentrators (Amicon). Activated kinases ranged from 30%-95% binds tightly to the kinase should be less sensitive to active based on a specific activity of 2-3 mol/min/mg for active protein and on gel shift analysis activation than those that contain two kinase-binding subunits. Hemiactive kinase dimers should work less Minden et al., 1995) . Events that depend goat antibody to rabbit or rat IgG and lissamine rhodamineon phosphorylation of multimeric substrates will be conjugated goat antibody to mouse IgG in PBS/bovine serum albumore sensitive to inhibition by overexpression of nonmin (Jackson ImmunoResearch) (Cheng et al., 1996) . In some experifunctional mutants than will those involving monomeric ments with Myc-ERK2, cells were fixed in 100% methanol at Ϫ20ЊC or methanol:ethanol (95:5) for 30 min at 25ЊC.
substrates. 
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